Table 1. Breast tumor and non‐tumor cell lines.
Cell lineGenetic subtypeERPRHer2TP53N‐cadherinShape cluster
hs578TBaB[−]+M++B
MCF10A (complete medium)BaB[−]+/−WT++L/B
MCF10A (base medium)BaB[−]+/−WT++L2
MDAMB157BaB[−]++B
MDAMB231BaB[−]++MB
SUM149BaB[−][−][+]+B
SUM159BaB[−][−][−]++L/B
HCC1143BaA[−]++M++B
HCC1954BaA[−]+[+/−]L1
HCC70BaA[−]++ML2
AU565Lu[−]++WTL2
BT474Lu+++L2
CAMA1Lu+[−]+L2
MCF7Lu+[+]+/−WTL1
MDAMB453Lu[−]−WTL2
SKBR3Lu[−]++B
T47DLu+[+]++ML1
ZR75.1Lu+[−]L2
JIMT1[−]+++L1
  • Gene cluster: Lu = luminal, BaA = Basal A, BaB = Basal B. ER/PR/HER2/TP53 status: +/− from protein and mRNA expression; [−] inferred from mRNA expression; M = mutant, WT = wild‐type (Neve et al, 2006). N‐cadherin status: +/− from mRNA expression and immunofluorescence (Supplementary Fig S1B). Shape clusters assigned from hierarchical clustering shown in Fig 1D.